Novo Nordisk's pricing procedures in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark distinction amongst U.S. prices and those in Europe and copyright.The maker claims that correct utilization of copyright, along with diet plan and workout, "may perhaps support